Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-01-26

Clinical Trial Update: Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial comparing CyberKnife SBRT versus VMAT SBRT for localized prostate cancer; no results are reported in the document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Juravinski Cancer Center | Conditions: Prostatic Neoplasms | Phase 2 | Status: UNKNOWN